#USA #Leesburg #Haier Biomedical #Resonant Clinical #LX-60T100R

Innovative Table Centrifuge with Natural Refrigerant: A Game Changer in Clinical Trials

In a significant collaboration between Resonant Clinical Solutions and Haier Biomedical, an innovative table centrifuge designed specifically for clinical studies has been introduced. This groundbreaking device, known as the LX-60T100R, operates using a natural refrigerant, showcasing a proactive stance towards upcoming changes to F-gas regulations in both Europe and the USA.

Meeting Environmental Standards Ahead of Time

This new centrifuge is not just about modern features; it's built to comply with stringent future regulations aimed at phasing out fluorinated greenhouse gases due to their high global warming potential (GWP). By utilizing hydrocarbon-based cooling (R290), the LX-60T100R significantly reduces its environmental impact compared to traditional F-gas units. With its introduction, the centrifuge reaches the market over two years ahead of critical deadlines set by industry standards.

Tailored for Clinical Environment

Developed with extensive input from professionals in the life sciences sector, the LX-60T100R is engineered to meet the demanding needs of pharmaceutical sponsors and contract research organizations (CROs). It enhances operational efficiencies while supporting widespread corporate commitments to sustainability. Its key features include:

• - Hydrocarbon Refrigeration: The centrifuge uses R290, which has a GWP reduced to around 3, a drastic drop from the over 1,400 associated with older F-gas systems.
• - Rapid Cooling: It can pre-cool from room temperature to 4°C in approximately five minutes, reducing wait times significantly compared to conventional systems.
• - Optimized Design: Engineered for routine tasks in clinical trials, it accommodates blood collection tubes, various Erlenmeyer flasks, and bottles up to 100 ml.
• - User-Friendly Interface: Equipped with a modern 7-inch LCD touchscreen that is responsive even when users are wearing gloves, it boasts features such as calibration setup, RFID rotor identification, user login management, and storage for over 1,000 programs.
• - Safety Monitoring: Advanced features include vibration detection, balancing tests, rotors' lifespan monitoring, and an extremely low center of gravity to limit vibrations.
• - Quiet Operation: Operating at just 52 dB(A), it’s ideal for shared lab environments, ensuring minimal disruption during long operations.

Designed for Accessibility

Weighing in at 46 kg, the LX-60T100R is compact and can easily fit on standard lab benches without requiring special structural reinforcements. This accessibility facilitates its integration into existing lab spaces, enhancing usability for researchers.

Leadership Statements

According to Christophe Berthoux, CEO of Resonant Clinical Solutions, "Our focus is on delivering premium, user-oriented solutions that encompass the whole lifecycle of complex clinical trial programs. Partnering with Haier Biomedical on this redesigned centrifuge with natural refrigerant has been crucial in providing a cutting-edge technology that meets and anticipates regulatory requirements for F-gases, fulfilling market demand well in advance of mandated deadlines. This leading-edge device makes centrifugation processes in clinical trials simpler, more flexible, and environmentally responsible."

Gang Liu, Co-CEO of Haier Biomedical, added, "Our ability to transition from concept to an innovative product in such a short time illustrates our commitment to supporting our customers. The biomedical sector continues to face new challenges, and we remain focused on collaborating with researchers to create novel solutions that significantly enhance workflows while minimizing harmful greenhouse gas usage."

Availability of the LX-60T100R

Clinical trial sponsors and CROs can exclusively purchase or rent the LX-60T100R through Resonant until November 2027. The model for 220–240 V AC, 50/60 Hz is currently available, while the 110 V AC model will debut in the first quarter of 2027. For more details, visit resonantclinical.com/products/centrifuges.

In conclusion, the LX-60T100R exemplifies the future of laboratory technology. It stands at the intersection of innovation, usability, and environmental consciousness, ultimately paving the way for more sustainable practices in clinical trials and beyond.